Revenues are expected to reach USD 9,672.1 million by 2034. The gadolinium industry size stands at USD 5,883.8 million in 2024. Demand is set to rise at a 5.2% CAGR until 2034.
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, is able to detect regions of damage and other disease-related features while using 60% less gadolinium — a chemical ...
Abstract: Despite the widespread use of gadolinium-based contrast agents in clinical MRI examinations due to their significant advantages in structural localization and tumor identification, there is ...
Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia with a reliable supply of Gadolinium-160 (Gd-160). This critical ...
MALMÖ, SWEDEN / ACCESS Newswire / February 7, 2025 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Q4 and Full Year Report for 2024 (January - December), which is ...
Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...